Valuation Biogen Inc. Xetra

Stocks

Market Closed - Xetra 11:35:45 2026-09-29 EDT			5-day change	1st Jan Change
198.98 ^EUR	-1.37%		+3.57%	+32.70%

09-23	AI-based drug developer Basecamp valued at $800 million after $140 million funding round	RE
09-17	Biogen Publishes Phase 3 Pediatric EMPAVELI Data Showing Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3g or Primary IC-MPGN	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	35,242	39,877	37,495	22,283	25,818	33,790	-	-
Change	-	13.15%	-5.97%	-40.57%	15.86%	30.88%	-	-
Enterprise Value (EV) ¹	37,820	40,560	43,384	26,204	28,289	38,727	36,210	33,138
Change	-	7.24%	6.96%	-39.6%	7.96%	36.9%	-6.5%	-8.48%
P/E	23.1x	13.3x	32.5x	13.7x	20x	37x	20.1x	16.3x
PBR	3.26x	3.02x	2.53x	1.33x	1.42x	1.82x	1.65x	1.49x
PEG	-	0x	-0.5x	0.3x	-0.9x	-1.2x	0.2x	0.7x
Capitalization / Revenue	3.21x	3.92x	3.81x	2.3x	2.61x	3.24x	3.17x	3.08x
EV / Revenue	3.44x	3.99x	4.41x	2.71x	2.86x	3.71x	3.4x	3.03x
EV / EBITDA	9.13x	11.2x	14.3x	7.1x	7.82x	13.9x	10.4x	9x
EV / EBIT	10.3x	13.1x	17x	8.69x	9.97x	15.4x	11.3x	9.44x
EV / FCF	11.2x	35.5x	34.2x	9.63x	13.8x	20.6x	14.4x	11.6x
FCF Yield	8.94%	2.82%	2.93%	10.4%	7.25%	4.86%	6.94%	8.61%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	10.4	20.87	7.97	11.18	8.79	6.131	11.31	13.94
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	10,982	10,173	9,836	9,676	9,891	10,444	10,658	10,954
EBITDA ¹	4,144	3,618	3,040	3,689	3,618	2,785	3,467	3,683
EBIT ¹	3,656	3,099	2,545	3,015	2,838	2,513	3,208	3,511
Net income ¹	1,556	3,047	1,161	1,632	1,293	996.8	1,859	2,196
Net Debt ¹	2,578	683	5,888	3,921	2,471	4,937	2,420	-652.2
Reference price ²	239.92	276.92	258.77	152.92	175.99	227.07	227.07	227.07
Nbr of stocks (in thousands)	146,893	144,001	144,898	145,719	146,702	147,754	-	-
Announcement Date	2/3/22	2/15/23	2/13/24	2/12/25	2/6/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MODERNA, INC.	-23.53x	35.76x	-23.21x	-.--%	78.76B
REGENERON PHARMACEUTICALS, INC.	17.14x	4x	9.43x	0.52%	75.12B
CSL LIMITED	21.02x	4.46x	13.83x	2.35%	61.14B
UCB	21.25x	4.71x	13.4x	0.69%	46.07B
SAMSUNG BIOLOGICS CO.,LTD.	34.11x	11.6x	22.25x	-.--%	47.57B
BIOGEN INC.	37.3x	3.71x	13.91x	-.--%	33.79B
INCYTE CORPORATION	56.5x	3.55x	27.54x	-.--%	25.3B
INNOVENT BIOLOGICS, INC.	61.04x	6.77x	40.51x	-.--%	21.34B
SWEDISH ORPHAN BIOVITRUM AB	23.03x	4.95x	12.88x	-.--%	15.36B
Average	27.54x	8.84x	14.50x	0.4%	44.94B
Weighted average by Cap.	18.96x	11.36x	8.98x	0.53%